BGF invests £3.1m in Renal Services

The fresh funds will enable the company to fund three new centres and provide working capital to enable the business to compete for additional contracts.

Following the deal, James Buckley will be appointed as non-executive chairman of the company. Buckley was previously CEO of Tunstall Group; non-executive director of Prism Medical; and chairman of Ark Home Healthcare and Mangar International.

BGF was attracted to the deal due to the projected increase in demand for kidney dialysis treatment in the UK, caused by an ageing population in the country.

Company
Founded in 2007 and headquartered in London, Renal Services is a provider of dialysis services to the British National Health Service. The company runs six dialysis centres with a total headcount of 62, providing care services to end-stage renal disease patients. These include clinical, quality control, data collection, diagnostics and maintenance services.

People
Stefano Ciampolini is CEO of Renal Services. Rory Pope, an investment director at BGF, will take a seat on the board of the company. George Tsangarides also worked on the deal for the GP.

Advisers
Equity – Charles Russell Speechlys (Legal).
Company – Shoosmiths (Legal).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• UK / Ireland
• Healthcare
• United Kingdom
• BGF (Business Growth Fund)